MAIA Biotechnology, Inc. (MAIA) earnings

MAIA earnings moved a median of +1.66% by the close. Quarterly and annual MAIA reports and results, each read against the price at its own news timestamp. Back to the MAIA overview →

13 measured MAIA earnings events.

Where these MAIA earnings landedvs 12 measured MAIA earnings reactions
MAIA earningsMiddle 50% · -0.44% to +5.63%Zero: 0.00%Median: +1.66%Median +1.66%-8.00%0+8.00%
Middle 50% of MAIA earnings reactions-0.44% to +5.63%
Median reaction (to close)+1.66%
Measured reactions12
Point-in-time · zero look-ahead

Half of the 12 MAIA earnings events with a measured close landed between -0.44% and +5.63%; 58% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q MAIA Biotechnology, Inc. For: Jun 30SEC filing · Form 10-Q+1.09%—
Form 10-Q MAIA Biotechnology, Inc. For: Mar 31SEC filing · Form 10-Q+3.10%+1.55%
Form 10-K MAIA Biotechnology, Inc. For: Dec 31SEC filing · Form 10-K+0.00%+2.06%
Form 10-Q MAIA Biotechnology, Inc. For: Sep 30SEC filing · Form 10-Q+0.03%+1.77%
Form 10-Q MAIA Biotechnology, Inc. For: Jun 30SEC filing · Form 10-Q-1.52%+0.00%
Form 10-Q MAIA Biotechnology, Inc. For: Mar 31SEC filing · Form 10-Q-0.49%-4.95%
Form 10-K MAIA Biotechnology, Inc. For: Dec 31SEC filing · Form 10-K-0.38%-1.76%
Form 10-Q MAIA Biotechnology, Inc. For: Sep 30SEC filing · Form 10-Q-0.96%-8.08%
Form 10-Q MAIA Biotechnology, Inc. For: Jun 30SEC filing · Form 10-Q+3.54%+6.30%
Form 10-Q MAIA Biotechnology, Inc. For: Mar 31SEC filing · Form 10-Q+2.79%+0.00%
Form 10-K MAIA Biotechnology, Inc. For: Dec 31SEC filing · Form 10-K-2.55%+7.65%
Form 10-Q MAIA Biotechnology, Inc. For: Sep 30SEC filing · Form 10-Q-5.08%+5.63%
MAIA Biotechnology Reports Third Quarter 2023 Financial Results and Highlights Recent Development Progress for Anticancer Asset THIOPress release-5.08%+5.63%
That’s how MAIA usually reacts to earnings — get an email when it moves on news →
Keep exploring

More MAIA: analyst actions → · SEC filings → · MAIA overview →